baber/WOPTO huggingface dataset:
Patent AU-618505-B2 (AU)
Title: Apparatus and method for providing a suture tab
Inventor: ERSKINE TIMOTHY J
IPC: A61M25/02
Filed: 1990-03-19
Granted: 1991-12-19
Abstract: A suture tab body has inside and outside surfaces and first and second parts with a line (24) therebetween. Openings (25) located about the first part pass through the body from the inside to the outside surface. Adhesion means (26) on a section of the inside surface is juxtaposed when the first and second parts are folded along the line. The openings in the first part are on another section apart from the adhesion means. A reinforcement (34) as a thicker area of the first part has ears (35) for the openings. The ears are adjacent a pair of opposite edges, each of which defines an elongate dimension of the body. At least two ears are disposed near each edge with one ear near each edge and the line. The adhesion means is a double faced foam tape (28) with a releasable covering for protecting an adhesive facing prior to use. A combination of suture tab and a catheter is used with a method for attaching the suture tab to the catheter (12). The method has the suture bab placed against the patient with the adhesive exposed to receive transversely the catheter. Folding the suture tab puts the outside surface of the second part away from the patient and the inside surface carrying the adhesive juxtaposed with the catheter and itself.
Patent AU-755606-B2 (AU)
Title: Ocular optical system simulating method and simulating apparatus
Inventor: QI HUA
IPC: A61B3/10
Filed: 1999-09-30
Granted: 2002-12-19
Abstract: There are provided an ocular optical system simulating method and a simulating apparatus which enable simulation of how things can be seen, together with fluctuation, deformation, blur, etc., occurring when a lens system such as a progressive addition lens is worn. A rotation-based retinal image, defined as an image obtained by turning an eye-ball with respect to all object points within a field of vision and by connecting images caught at the fovea, is made. The image is made by first creating an original image having a specific angular field of vision and entering the eye having a specific rotation center point. Then, a deformed original image having deformation occurring when the original image is seen through the lens system is created by using ray tracing. A PSF on the retina of an eye-model from light from the object points of the original image in an optical system composed of the lens system and a spectacle model is determined. Next, the deformed original image and the PSF of each pixel of the original image are convoluted. The obtained rotation-based retinal image is edited further to result in a motion picture image of the rotation-based retinal image. The PSF is found by selecting sampling points on an object and the PSF other than those at the sampling points is found by using approximation methods including spline interpolation. <IMAGE>
Patent AU-563683-B2 (AU)
Title: Substituted acyl derivative of 1,2,3,4-tetrahydroiso- quinoline-3-carboxylic acid
Inventor: HOEFLE MILTON L
IPC: A61K31/472
Filed: 1986-02-04
Granted: 1987-07-16
Abstract: There are disclosed substituted acyl derivatives of 1,2,3,4-tetrahydro-5,7-dimethoxy-3-isoquinoline-carboxylic acid having the following general formula: <CHEM> wherein R<2> is a hydrogen atom or a methyl or ethyl radical, and pharmaceutically acceptable salts of the compound of formula I. The substituted acyl derivatives and the pharmaceutically acceptable salts thereof may be produced by coupling a suitably substituted 1,2,3,4-tetrahydroisoquinoline with a suitably substituted amino acid and, when desired, hydrolysing or removing the protecting groups of the resulting product. The compounds of the invention, their salts and pharmaceutical compositions thereof are useful as anti-hypertensive agents.
Patent AU-576285-B2 (AU)
Title: Snap-on sunglasses
Inventor: GAZELEY ALBERT E
IPC: G02C7/08
Filed: 1986-02-18
Granted: 1988-08-18
Abstract: There is disclosed an improved optical accessory (10) of the sun shade type for use with a pair of prescription spectacles (12). The accessory (10) includes a releasable securing structure (54) which releasably cooperates with a bridge assembly (30) of the spectacles to inhibit movement of the accessory (10) relative thereto. '
Patent AU-774508-B2 (AU)
Title: Card for counting and characterising micro-organisms
Inventor: COLIN BRUNO
IPC: B01L3/00
Filed: 1999-09-01
Granted: 2004-07-01
Abstract: The invention concerns an analysis card as well as a method for filing such a card and the use of said card. Said card comprises a body consisting of: a zone for injecting into the card a biological fluid to be analyzed; a main duct supplying the biological fluid coming from the injection zone; at least two secondary ducts located in the extension of the main duct; and at least one well corresponding to each secondary duct. The invention is characterized in that each well constitutes a means for dispensing a specific volume of said biological fluid into at least two terminal analysis ducts, via a terminal duct for each analysis cavity and the volume to be analyzed is less than the total volume of all the analysis ducts. Although this concerns a particular embodiment wherein a biological fluid is transferred in parallel, in another embodiment the transfer may be carried out in series. The invention is particularly applicable in microbiology.
Patent AU-530060-B2 (AU)
Title: Amino pyridine derivatives
Inventor: GREVE WILFRIED
IPC: C07D401/04
Filed: 1980-01-07
Granted: 1983-06-30
Abstract: 4-Aminopyridines of the formula   <IMAGE>   in which R1 is hydrogen or alkyl of up to 6 carbon atoms and R2 represents (a) alkyl of up to 6 carbon atoms substituted up to three times with at least one radical from the group of halogen and hydroxyl, with formyl acetalized with an alcohol of up to 3 carbon atoms, alkylthio of up to 3 carbon atoms, phenylthio or the corresponding alkyl- and phenyl-sulfoxy and sulfone groups, the phenyl ring optionally carrying in each case up to three substituents from the group of alkyl, alkyl halide, alkoxy, mono- or dialkylamino having each up to 4 carbon atoms in each alkyl radical, halogen, nitro, amino and hydroxy, or (b) phenylalkyl or diphenyl-alkyl of up to 6 carbon atoms in the linear or branched alkyl moiety, the phenyl rings optionally being substituted up to three times with at least one radical from the group of alkyl, alkoxy, alkyl halide with up to 4 carbon atoms each, halogen, amino, hydroxy, nitro, the sulfamoyl group and the methylene dioxy radical, or R1 and R2, together with the nitrogen atom present in the 4-position, form a five- to seven-membered heterocyclic ring optionally substituted with alkyl of up to 2 carbon atoms and including up to two hetero-atoms, the second hetero-atom being oxygen, sulfur optionally carrying up to two oxygen atoms, or nitrogen, and R3 and R4 which may be identical or different, each represent alkyl of up to 9 carbon atoms, one of the two radicals optionally also being hydrogen, Y is a nitro or a cyano group, and Z stands for hydrogen or halogen, and the physiologically acceptable salts of these compounds, processes for their preparation and medicaments made thereof.
Patent AU-694655-B2 (AU)
Title: Composition for oral administration
Inventor: YAJIMA TOSHIO
IPC: A61K9/00
Filed: 1996-04-30
Granted: 1998-07-23
Abstract: ÄObjectÜ To provide a composition for oral administration which is excellent in masking a taste of an unpleasant tasting drug and in bioavailability. ÄConstitutionÜ A composition for oral administration comprising an unpleasantly tasting drug, a high polymer soluble in the stomach and a monoglyceride in the  beta -crystal form.
Patent AU-567006-B2 (AU)
Title: Three dimensional inorganic oxide structures
Inventor: ARAYA ABRAHAM
IPC: C04B38/00
Filed: 1986-04-28
Granted: 1987-11-05
Abstract: This invention provides a three dimensional inorganic oxide structure comprising a myriad of cavities interconnected by holes having a narrow pore size distribution, in which the diameters of the cavities is in the range from 1 to 50  mu m and that of the holes in the range 1 to 10  mu m and in which the pore volume in the range 1 to 10  mu m is at least 2 cc/g and in which the inorganic oxide is selected from alumina, silica, titania, zirconia and mixtures thereof and a process for the preparation of such structures.
Patent AU-771737-B2 (AU)
Title: Taxane derivatives and processes for the preparation thereof
Inventor: BOMBARDELLI EZIO
IPC: C07D493/00
Filed: 2000-07-03
Granted: 2004-04-01
Abstract: The invention discloses an oxazolidine intermediate for the synthesis of 14- beta -hydroxy-1,14-carbonate-baccatines bearing a 13-isoserine substituent, and a process for the preparation thereof.
Patent AU-724411-B2 (AU)
Title: Method and means for detecting chemicals on ground
Inventor: BERGLUND TAGE
IPC: G01N33/00
Filed: 1998-02-20
Granted: 2000-09-21
Abstract: PCT No. PCT/SE98/00300 Sec. 371 Date Aug. 19, 1999 Sec. 102(e) Date Aug. 19, 1999 PCT Filed Feb. 20, 1998 PCT Pub. No. WO98/37398 PCT Pub. Date Aug. 27, 1998The invention relates to a method and means for detecting chemical contaminants on the ground. A tracked or wheeled vehicle is driven on the ground in question and a sampling screen (2) arranged as a mudflap in connection with at least one track/wheel of the vehicle is thereby contaminated by particles (3) thrown up from the ground, and an air stream carrying substances evaporated from said particles is caused to flow from said sampling screen (2) through a conduit (6) via a detection unit (4) in the vehicle. The sampling screen (2) is preferably provided with a heating device (11) to enhance the evaporation of possible chemicals from said particles.
Patent AU-772310-B2 (AU)
Title: New cytotoxic pyrido(2,3,4-kl)acridine derivatives, their preparation and their therapeutic use
Inventor: FELIU LIDIA
IPC: A61K31/4375
Filed: 2000-07-27
Granted: 2004-04-22
Abstract: The invention provides compounds of formula (I)whereinR1 represents a hydrogen atom, an alkyl group having from 1 to 6 carbon atoms, a hydroxy group, an alkoxy group having from 1 to 6 carbon atoms, a halogen atom, a nitro group, an amino group, a monoalkylamino group wherein the alkyl moiety has from 1 to 6 carbon atoms, a dialkylamino group wherein each alkyl moiety may be the same or different and each has from 1 to 6 carbon atoms, a dialkoxyamino group wherein each alkoxy moiety may be the same or different and each has from 1 to 6 carbon atoms, an alkanoyalmino group having from 1 to 20 carbon atoms or an alkanesulfonylamino group having from 1 to 6 carbon atoms;R2 represents a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms; andR3 represents a hydrogen atom, an alkyl group having from 1 to 6 carbon atoms or an alkoxy group having from 1 to 6 carbon atoms;and pharmaceutically acceptable salts thereof. The compounds exhibit activity against a wide variety of mammalian cancer cell lines.
Patent AU-671013-B2 (AU)
Title: Blunt tipped ultrasonic trocar
Inventor: VAITEKUNAS JEFFREY J
IPC: A61B17/34
Filed: 1994-05-12
Granted: 1996-08-08
Abstract: A blunt tipped trocar which uses ultrasonic energy in the form of vibrations to assist a user in penetrating tissue. In one embodiment of the invention, a feedback mechanism is provided which senses a variation in load on the trocar tip and adjusts the ultrasonic energy level of the vibrating tip in accordance with the load condition. Another embodiment of the invention provides a trocar with a self-contained ultrasonic generator.
Patent AU-585414-B2 (AU)
Title: Process for the preparation of cefodizime
Inventor: JAENICKE OTTMAR
IPC: C07D501/36
Filed: 1986-12-02
Granted: 1989-06-15
Abstract: A process for the preparation of cefodizime of the formula   <IMAGE> +TR   <IMAGE>  wherein (a) a compound of the formula II (ATS) <IMAGE>   wherein R1 represents hydrogen or an aminoprotective group and A represents a hydrogen atom or one equivalent of an alkali metal or alkaline earth metal, of ammonium or of an organic nitrogen base, is first reacted with a compound of the formula III R-SO2Hal  wherein R represents an optionally substituted alkyl, aryl or aralkyl radical and Hal represents a halogen atom, in an organic solvent and, if appropriate, in the presence of a base, (b) a compound of the formula I (TACS)   <IMAGE>    in which A has the above meaning, is reacted with a silylating agent in an organic solvent and, if appropriate, in the presence of a base, and (c) the two products formed in (a) and (b) are reacted in their reaction solutions, and any protective group R1 present in the end product of the formula I is eliminated.
Patent AU-749750-B2 (AU)
Title: Pyrido {2,3-d} pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
Inventor: BOSCHELLI DIANE HARRIS
IPC: A61P17/06
Filed: 1998-01-26
Granted: 2002-07-04
Abstract: This invention provides pyridopyrimidines and 4-aminopyrimidines that are useful for treating cell proliferatives disorders, such as cancer and restenosis. We have now discovered a group of 7,8-dihydro-2-(amino and thio)pyrido[2,3-d]pyrimidines and 2,4-diaminopyrimidines that are potent inhibitors of cyclin-dependent kinases (cdks) and growth factor-mediated kinases. The compounds are readily synthesized and can be administered by a variety of routes, including orally, and have sufficient bioavailability. This invention provides compounds of Formula (I) and Formula (II) where W is NH, S, SO, or SO2, R<1> includes phenyl and substituted phenyl, R<2> includes alkyl and cycloalkyl, R<3> includes alkyl and hydrogen, R<8> and R<9> include hydrogen and alkyl, and Z is carboxy. This invention also provides pharmaceutical formulations comprising a compound of Formula (I or II) together with a pharmaceutically acceptable carrier, diluent, or excipient therefor.
Patent AU-772126-B2 (AU)
Title: New polycyclic azaindole compounds, a process for their preparation and pharmaceutical compositins containing them
Inventor: GUILLAUMET GERALD
IPC: A61P25/00
Filed: 2000-10-13
Granted: 2004-04-08
Abstract: Polycyclic azoindoline derivatives (I), their enantiomers, diastereoisomers, and salts with acids and bases, their preparation, intermediates for their preparation, and pharmaceutical compositions containing them are new. Polycyclic azoindoline derivatives of formula (I) in which the dotted line indicates an optional unsaturation, and the group of formula (a) = a group (b), (c), (d) or (e); R<1> = halogen, -R, -OR, -S(O)nR, -NRR', -NR-CZ-R', -NR-CZ-OR', -NR-CZ-NR'R, -NR-SO2-R', -CZ-NR'R, or -SO2-NR'R; n = 0, 1 or 2; Z = S or O; R, R', and R = H, 1-6C alkyl, 2-6C alkenyl or alkynyl, all of which may be substituted, 3-8C cycloalkyl optionally substituted, cycloalkyl alkyl optionally substituted, aralkyl, heteroaryl, heteroaryl alkyl, or R' may form, with R or R and the N atom to which they are attached, a morpholino, piperidinyl, piperazinyl, or pyrrolidinyl group which may be substituted; G1 = 1-4C alkylene that may be substituted by R, OR, -COR, or -COOR, or it is a 1-4C alkylene chain in which one of the methylene groups is replaced by 3-8C cycloalkylene; A = - -CZ-NRR', -NR-CZ-R', or -NR-CZ-NR'R; B' forms with the N atom and the C atom to which it is attached = a 5-8 membered chain that may be saturated or unsaturated and may contain a further O, N, or S heteroatom; R<2> and R<3> = H, 1-6C alkyl or alkoxy, or OH, or together they form an oxo group; R<4> and R<5> = H or together with two adjacent C atoms on ring B form an aryl or heteroaryl group. The optional substituents on alkyl, alkenyl, alkynyl, cycloalkyl morpholinyl, piperidinyl, piperazinyl and pyrrolidinyl groups may be OH, oxo, alkoxy, alkyl, polyhaloalkyl, or halogen. The optional substituents on cycloalkylalkyl groups may be one or more OH, oxo, alkoxy, alkyl, polyhaloalkyl, or halogen groups on the cyclic group. The term aryl covers phenyl, naphthyl, or biphenyl, these being optionally substituted by one or more OH, alkoxy, alkyl, amino, mono- or di-alkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxy, alkoxycarbonyl, amido or halogens. The term heteroaryl covers furyl, pyrrolyl, imidazolyl, pyridyl, thienyl, pyrazinyl, benzothienyl, benzofuranyl, indolyl, benzimidazolyl, quinolyl, or quinazolinyl, these being optionally substituted by one or more OH, alkoxy, alkyl, amino, mono- or di-alkylamino, nitro, cyano, polyhaloalkyl, formyl, carboxy, amido or halogens. An Independent claim is included for intermediates of formula (XVII).
Patent AU-645508-B2 (AU)
Title: Imidazoquinoxaline compounds, their preparation and use
Inventor: WATJEN FRANK
IPC: A61P25/00
Filed: 1990-11-22
Granted: 1994-01-20
Abstract: New imidazoquinoxaline compounds having the general formula I <IMAGE> (I)  wherein  <IMAGE>  wherein R1 and R2 independently are hydrogen, straight or branched C1-6-alkyl, or C3-7-cycloalkyl; R3 is hydrogen, straight or branched C1-6-alkyl, straight or branched C2-6-alkenyl, or aralkyl or aroylalkyl which may optionally be substituted with halogen or C1-6-alkoxy; R4 and R5 independently are hydrogen, halogen, C1-6-alkyl or trifluoromethyl. The compounds are useful in psychopharmaceutical preparations as anticonvolusants, anxiolytics, hypnotics and in improving the cognitive function of the brain of mammals.
Patent AU-590384-B2 (AU)
Title: Active attenuation system with on-line modeling of speaker, error path and feedback path
Inventor: ERIKSSON LARRY J
IPC: H03H11/24
Filed: 1987-02-05
Granted: 1989-11-02
Abstract: An active acoustic attenuation system is provided that actively models direct and feedback paths as well as characteristics of the secondary cancelling sound source and the error path on an on-line basis. The primary model uses a recursive least mean squares RLMS algorithm that is excited by the input acoustic noise and uses the residual acoustic noise as an error signal. The secondary sound source or cancelling speaker and the error path are modeled by a second algorithm, particularly an LMS algorithm, that uses an additional auxiliary low level, random, uncorrelated noise source as an input signal. The resulting overall system provides excellent attenuation of narrow band and broad band noise over a relatively wide frequency range on a completely adaptive basis without directional transducers.
Patent AU-757158-B2 (AU)
Title: Wall frame assembly table
Inventor: OLDEN MARC
IPC: B27M3/00
Filed: 2000-11-01
Granted: 2003-02-06
Abstract: A wall frame assembly table (10; 110) for rapid assembly of wall frames (W; W'; W'') at a central location for shipment to a construction site. The wall frame assembly table (10; 110) can be configured for construction of wall frames (W; W'; W'') of different shapes and sizes. The table (10; 110) is constructed to inhibit the accumulation of debris on the table (10; 110) for consistently accurate placement of the wall frame elements (B, T, S, J, C. H. O, D). Locating pins (34D, 36D; 134D, 136D) along the sides of the table (10; 110) engaging the wall frame elements (B, T, S, J, C, H. O, D) can be selectively removed as needed for driving nails through the elements (B, T, S, J, C, H. O, D). An adjustable support (40; 140) is provided for the top plate (T) of the wall frame (W; W'; W'') which can be extended to different distances from an edge of the table (10; 110) for walls of different height. In addition, the adjustable support (40; 140) can be angled in correspondence with a wall frame (W; W'; W'') which has a top plate (T) extending to an angle relative to the bottom plate (B). A laser projection system may be used to locate the elements (B, T, S, J, C, H, O, D) of the wall frame (W; W'; W''). However, the table (10; 110) may include an offset locator (205, 207) to permit entirely manual setup and assembly with minimal effort and skill. <IMAGE>
Patent AU-717470-B2 (AU)
Title: Process and apparatus for controlling the degree of attrition of a sealing screw conveying a plasticized material
Inventor: BACHER HELMUT
IPC: B29C48/74
Filed: 1998-04-20
Granted: 2000-03-30
Abstract: An apparatus and a method for controlling a degree of attrition or wear of a sealing screw conveying plasticized material are provided. The apparatus includes an opening which intersects the wall of a housing of the screw in the region of the screw threads or in the region immediately neighboring the screw threads. Another opening intersects the wall of the housing. The two openings are spaced apart axially from each other and the pressure sensors connected to both openings. The process involved conveys a plasticized material against a resistance, the resistance being a sealing screw bearing supported within the screw housing. The pressure of the conveyed material is measured at two locations spaced apart from each other in the direction of conveyance. The two locations are disposed on both sides of a resistance body towards which the sealing screw conveys the material. The difference between the two measured values is used to indicate the degree of wear of the screw or its housing, respectively.
Patent AU-633198-B2 (AU)
Title: Vasoactive vasotocin derivatives
IPC: A61K38/095
Filed: 1991-02-26
Granted: 1993-01-21
Abstract: PCT No. PCT/SE91/00154 Sec. 371 Date Sep. 23, 1992 Sec. 102(e) Date Sep. 23, 1992 PCT Filed Feb. 26, 1991 PCT Pub. No. WO91/13092 PCT Pub. Date Sep. 5, 1991.The present invention relates to new vasotocin derivatives with prolonged activity compared to previous vasotocin derivatives. In particular, the vasotocin derivatives of the present invention are of the formula (I)   <IMAGE>   wherein Hmp is a 2-hydroxy-3-mercaptopropionic acid residue,   <IMAGE>   Z is Phe or Tyr, Y is Hgn or Hci, X is a residue of the formula   <IMAGE>   wherein Q is H, alanyl or L-2-aminobutyryl and n is 1, 2 or 3. The present invention also relates to pharmaceutical compositions containing these vasotocin derivatives.
Patent AU-677696-B2 (AU)
Title: New bis-naphthalimides for the treatment of cancer
Inventor: KEILHAUER GERHARD
IPC: A61K31/47
Filed: 1994-08-08
Granted: 1997-05-01
Abstract: Disclosed herein are compounds pharmaceutical compositions containing same of the formula 1. A compound of the Formula   <IMAGE>   wherein X, X', X'' and X''', A, B, D, R, and R' are as identified in the specification and their preparation. Pharmaceutical compositions containing same can be used in the treatment of cancer.
Patent AU-591416-B2 (AU)
Title: Anti-seizing design for circumferentially continuous piston ring
Inventor: MELCHIOR JEAN FREDERICK
IPC: F16J1/04
Filed: 1987-08-13
Granted: 1989-11-30
Abstract: A continuous ring with inside diameter (DinR) larger than the outside diameter (DoutR) of the piston irrespective of conditions of operation. The ring's outside diameter when measured outside the cylinder equals or slightly exceeds the inside diameter of the cylinder. The ring is sized and designed according to various parameters determined so as to prevent piston seizing in the cylinder.
Patent AU-635644-B2 (AU)
Title: Dual converter engine exhaust system for reducing hydrocarbon emissions
IPC: B01D53/94
Filed: 1991-06-03
Granted: 1993-03-25
Abstract: An engine exhaust system and method of controlling hydrocarbon emissions are provided. The system and method are based on the use of two catalytic converter chambers, a first chamber containing a catalytic material and a second chamber containing catalyst as well as molecular sieves capable of adsorbing hydrocarbons during engine start-up and of having hydrocarbons desorbed therefrom when the catalysts reach an effective converting temperature. According to the invention, engine exhaust is selectively conveyed to each of the two converters in a manner such that initially produced hydrocarbon is withheld in the system by the molecular sieves in order to be recycled through the converters and brought into contact with the catalyst after an effective converting temperature has been attained.   <IMAGE>